MA Horn, AW Trafford - Journal of molecular and cellular cardiology, 2016 - Elsevier
Cardiovascular disease is a leading cause of death worldwide and there is a pressing need for new therapeutic strategies to treat such conditions. The risk of developing cardiovascular …
Background Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies …
Objectives: The aim of this study was to assess the effects of serelaxin on short-term changes in markers of organ damage and congestion and relate them to 180-day mortality …
Y Fang, V Gupta, R Karra, JE Holdway… - Proceedings of the …, 2013 - National Acad Sciences
Certain lower vertebrates like zebrafish activate proliferation of spared cardiomyocytes after cardiac injury to regenerate lost heart muscle. Here, we used translating ribosome affinity …
Studies in the gravid rat model revealed a key role for the corpus luteal hormone, relaxin, in the maternal circulatory changes of early pregnancy epitomized by profound systemic …
Patients admitted for acute heart failure (AHF) experience high rates of in‐hospital and post‐ discharge morbidity and mortality despite current therapies. Serelaxin is recombinant human …
Fibrosis refers to the hardening or scarring of tissues that usually results from aberrant wound healing in response to organ injury, and its manifestations in various organs have …
AA Pinar, TE Scott, BM Huuskes, FET Caceres… - Pharmacology & …, 2020 - Elsevier
Cardiovascular fibrosis refers to the scar tissue that develops in the injured heart and blood vessels from an aberrant wound healing response to organ injury or insult. Established …
Abstract Relaxin, insulin-like peptide 3 (INSL3), relaxin-3, and INSL5 are the cognate ligands for the relaxin family peptide (RXFP) receptors 1–4, respectively. RXFP1 activates …